» Articles » PMID: 36945302

Poorly Differentiated Thyroid Carcinoma: An Institutional Experience

Overview
Specialty Oncology
Date 2023 Mar 22
PMID 36945302
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The incidence of poorly differentiated thyroid carcinoma (PDTC) is extremely low among thyroid cancers and there is no standardized treatment guideline for it. In this study, we have analyzed PDTC patients and reviewed their clinicopathological features.

Methods: Data of PDTC patients from our institution are collected through the electronic medical database. We analyzed them by several parameters such as basic demographics, presenting symptom, preoperative cytology results, associated pathology, surgical results, surgery type, and distant metastasis.

Results: We collected 23 cases in our institution. Apart from two patients who were transferred to another hospital upon diagnosis, all 21 operated cases are analyzed. The parameters we studied were age, sex, presenting symptoms, distant metastasis and pathological features such as tumor size, associated pathology, predominant pattern and so on. We also provided descriptive analyses according to the type of presentation and treatment; patients with distant metastasis, juvenile cancer, and concurrent hyperthyroidism. Furthermore, we provided different cases in which the initial surgical plans differed.

Conclusion: We present 21 cases of PDTC patients and clarify their clinicopathological features. Despite some limitations, this study may shed light for future research regarding treatment of PDTC patients.

Citing Articles

The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review.

Violetis O, Konstantakou P, Spyroglou A, Xydakis A, Kekis P, Tseleni S J Pers Med. 2024; 14(6).

PMID: 38929875 PMC: 11205159. DOI: 10.3390/jpm14060654.

References
1.
Foroughi F, Saadat N, Salehian M . Encapsulated insular carcinoma of the thyroid arising in graves' disease: report of a case and review of the literature. Int J Surg Pathol. 2012; 20(6):636-9. DOI: 10.1177/1066896912449688. View

2.
Hiltzik D, Carlson D, Tuttle R, Chuai S, Ishill N, Shaha A . Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 2006; 106(6):1286-95. DOI: 10.1002/cncr.21739. View

3.
Chernock R, Rivera B, Borrelli N, Hill D, Fahiminiya S, Shah T . Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Mod Pathol. 2020; 33(7):1264-1274. PMC: 7329587. DOI: 10.1038/s41379-020-0458-7. View

4.
Walczyk A, Kowalska A, Sygut J . The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma) - own observations. Endokrynol Pol. 2010; 61(5):467-73. View

5.
Belfiore A, Russo D, Vigneri R, Filetti S . Graves' disease, thyroid nodules and thyroid cancer. Clin Endocrinol (Oxf). 2002; 55(6):711-8. DOI: 10.1046/j.1365-2265.2001.01415.x. View